Lean is addictive because it contains codeine, an opioid that triggers the same brain reward pathways as morphine and heroin. Mixed into soda and candy for flavor, the drink disguises a genuinely dangerous combination: codeine paired with promethazine, an antihistamine that amplifies and extends the opioid high. What feels like a mellow, slow-sipping buzz is actually two central nervous system depressants working together to reshape your brain’s reward chemistry with repeated use.
What Lean Actually Contains
Lean starts with prescription cough syrup containing two active drugs. A standard teaspoon (5 mL) delivers 10 mg of codeine phosphate and 6.25 mg of promethazine hydrochloride in a flavored syrup base that also contains 7% alcohol. Users typically pour several ounces of syrup into a large cup of soda, often Sprite or Mountain Dew, sometimes with a Jolly Rancher dissolved in it. A single cup can contain many times the recommended dose of both drugs.
The sweet taste and casual drinking ritual mask what is, pharmacologically, a potent opioid-sedative cocktail. That disconnect between how it looks and what it does is part of what makes lean so easy to underestimate.
How Codeine Hijacks Your Reward System
Codeine is a prodrug, meaning your body has to convert it into something else before it fully works. A liver enzyme called CYP2D6 converts about 5 to 10% of each codeine dose into morphine, which is the compound responsible for the painkilling and euphoric effects. The remaining 80% or so gets converted into inactive byproducts that do nothing. This means the “high” from codeine is literally a morphine high, just delivered through a slower, less efficient route.
Once morphine reaches the brain, it locks onto mu-opioid receptors, the same receptors targeted by heroin and fentanyl. These receptors exist in two subtypes. One is responsible for pain relief and physical dependence. The other drives euphoria, dependence, and the slowed breathing that makes opioid overdoses fatal. When morphine activates these receptors, it suppresses a chemical called GABA, which normally keeps dopamine in check. With that brake removed, dopamine floods into the nucleus accumbens, a deep brain structure central to reward, motivation, and habit formation. Dopamine neurons in this region are what make you feel pleasure from food, sex, or accomplishment. Opioids produce a dopamine surge far beyond what natural rewards generate, which is why the feeling is so powerfully reinforcing.
At the cellular level, opioid binding causes neurons to become less excitable. Potassium channels open, calcium channels close, and the net effect is a wave of neural quieting that produces the characteristic warmth, relaxation, and emotional blunting lean users describe.
How Promethazine Intensifies the High
Promethazine is not an opioid. It’s an antihistamine with strong sedative properties, originally used in the 1950s as an “opioid-sparing” agent, meaning doctors discovered it could enhance the effects of lower opioid doses. That same property is exactly what makes it dangerous in lean. Promethazine potentiates the sedation from codeine, making the combined effect stronger and longer-lasting than codeine alone.
Users who have taken both drugs together report that the high feels distinct from taking an opioid by itself. The combination has been described in clinical literature as highly addictive. Promethazine also has anti-nausea effects, which conveniently suppress one of codeine’s most common side effects (vomiting), letting users consume larger amounts without their body’s natural warning signals kicking in.
Why Your Brain Demands More Over Time
With repeated use, the brain fights back against the artificial dopamine flood. Opioid receptors gradually pull back from the cell surface in a process called downregulation, becoming fewer in number and less sensitive to stimulation. The degree and speed of this tolerance depends on dose and frequency, but the result is always the same: the amount that once produced euphoria barely registers, pushing users to drink more syrup, more often.
This tolerance develops on multiple fronts simultaneously. The body also speeds up its metabolism of codeine, breaking it down faster. And the brain’s own opposing systems ramp up, counteracting the calming effects of the drug. Together, these adaptations mean that a regular lean user isn’t just chasing the original high. They’re also trying to feel normal, because their baseline brain chemistry has shifted to account for a drug that’s no longer optional.
What Withdrawal Feels Like
Once physical dependence sets in, stopping lean triggers a predictable set of withdrawal symptoms. These include muscle aches, diarrhea, nausea and vomiting, excessive sweating, a racing heart, dilated pupils, sensitivity to light, insomnia, runny nose, watery eyes, goosebumps, and yawning. The body essentially overreacts to the sudden absence of the opioid it had been compensating for, with systems that were suppressed now firing on overdrive.
Withdrawal is rarely life-threatening on its own, but it is intensely uncomfortable, and the knowledge that another cup of lean will make all of it disappear within minutes is what drives relapse. This is the trap of opioid dependence: the drug creates the very misery it then promises to relieve.
Why Lean Carries Serious Physical Risks
Both codeine and promethazine independently slow breathing. Promethazine depresses the respiratory center through a mechanism that is separate from and additive to codeine’s effect. This means the two drugs don’t just double the risk of dangerously slow breathing; they compound it in ways that are hard to predict, especially at the high doses typical of recreational use.
Adding alcohol, benzodiazepines, or other sedatives to the mix raises the danger further. Observational studies have shown that combining opioids with other central nervous system depressants significantly increases the risk of fatal overdose compared to opioids alone. Because lean is sipped slowly and socially, users may not realize how much they’ve consumed until respiratory depression is already setting in. The FDA label for codeine-promethazine syrup warns that life-threatening breathing problems can occur at any time during use but are most likely early on, before tolerance develops, or whenever another depressant enters the picture.
Genetic Differences That Change the Risk
Not everyone processes codeine the same way. The CYP2D6 enzyme that converts codeine to morphine varies dramatically from person to person based on genetics. Some people are “poor metabolizers” who convert very little codeine to morphine and feel almost no effect. Others are “ultra-rapid metabolizers” whose bodies produce far more morphine than expected from a standard dose. For ultra-rapid metabolizers, a few ounces of lean can produce morphine levels equivalent to a much stronger opioid, increasing both the addictive pull and the overdose risk. You have no way of knowing which category you fall into without genetic testing, which means every new user is essentially gambling on their own enzyme profile.